Loading...
Market
Where will the first clinical trial of biodegradable silk hydrogel battery be conducted by end of 2025?
2
Resolution / Starting Odds
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Clinical trial registries and announcements
Story
Smallest Soft Biodegradable Silk Hydrogel Battery Controls Heartbeats as Defibrillator in Mice
Oct 25, 2024, 10:22 AM
Recent advancements in bioelectronics and battery technology have led to the development of a biodegradable battery capable of controlling heartbeats. This innovative lithium-ion battery, constructed from three droplets of silk-based hydrogel, is noted for being the smallest soft battery of its kind. Researchers have demonstrated its potential to function as a defibrillator or pacemaker in ex vivo tests on mouse hearts. The implications of this technology extend to powering biodegradable, minimally invasive medical implants and devices, marking a significant step forward in bio-integrated technology.
View original story
Similar markets
United States • 25%
Europe • 25%
Asia • 25%
Other • 25%
Medical Devices • 25%
Robotics • 25%
Consumer Electronics • 25%
Other • 25%
MIT • 25%
Harvard • 25%
Mass Eye and Ear • 25%
Columbia • 25%
Yes • 50%
No • 50%
Improved Learning Algorithm • 25%
New Game Mastery • 25%
Commercial Prototype • 25%
Other • 25%
Phase 1 • 25%
Phase 2 • 25%
Phase 3 • 25%
No trial • 25%
Government grants • 25%
Private investors • 25%
Pharmaceutical companies • 25%
Non-profit organizations • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Johns Hopkins • 25%
Other • 25%